The Government of Canada is taking steps to strengthen Canada’s vaccine manufacturing capacity – but this will not be soon

The $ 415 million federal funding announced on Wednesday is set to help Sanofi build a new vaccine manufacturing facility in Toronto that will eventually have the tools to manufacture, fill, and inspect vaccines on a large scale

Sanofi, which already has a manufacturing facility in North York, Ont., will also receive $ 55 million from the Ontario government. The company itself will invest at least $ 79 million a year to fund Canadian research and development / p>

According to the government, when completed, the facility will be able to produce enough doses of vaccine to “support the entire Canadian population within about six months” after a global pandemic influenza was reported

As the project is not expected to be completed by 2026, the project is touted as an important addition to the future preparation for the pandemic in Canada

“If we learn a lesson from the current COVID-19 pandemic, we must have a strong Canadian organic production sector so that we as a nation are prepared for when the next pandemic hits – whatever it is,” said François- Philippe Champagne, Canada’s Minister for Innovation, Science and Industry

Canada’s lack of domestic vaccine manufacturing capacity has been heavily criticized in the wake of the COVID-19 pandemic. Without a homegrown vaccine maker, Canada cleared several hurdles in adopting the vaccine

The Canadian government has claimed Canada stays on track with its vaccination schedule but is falling behind globally, especially when compared to countries like the USAS, Israel and the UK

The majority of Canada’s COVID-19 vaccines are made and shipped from Europe, some come from the US. and India too

The dynamic has at times brought Canada to political stressors in a global race for shots.The European Union has come to grips with the threat of export controls on its homegrown vaccines in order to vaccinate its citizens first, and faster Canada has insisted that such vaccines be exported Measures would not affect the arrival of its contracted doses

In a normal year Canada imports about 85 percent of its vaccines – a huge shift from the 1970s when Canada manufactured the vast majority of its own vaccines

Prime Minister Justin Trudeau has recognized in the past that Canada needs to do more to boost its organic production sector. Back in February, the government announced a preliminary deal with US Vaccine maker Novavax, which would allow a Montreal-based facility to manufacture the vaccine once it is approved for use in Canada

This facility is still under construction and is likely months away from being ready and approved to pump vaccines

Earlier this year, the company agreed to fill and package millions of vaccine doses from Pfizer-BioNTech and Johnson & Johnson, both of which have been approved for use in Canada

Last month, the company partnered with GlaxoSmithKline to start a new clinical trial of a protein-based COVID-19 vaccine candidate that experienced a delay late last year

A separate human study of an mRNA vaccine candidate with Translate Bio has also started


World News – CA – Vaccines From Canada: Canada Injects Millions Into Future Sanofi Plants